Cramer’s lightning round: I prefer Moderna stock over Novavax

CNBC Television published this video item, entitled “Cramer’s lightning round: I prefer Moderna stock over Novavax” – below is their description.

“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • NASA predicts giant asteroid could hit Earth in 2182
  • Family members push to make Surfside condo collapse sight a memorial
  • Analyst Ivy Zelman sees a lot of ‘red flags’ in housing market and is staying on the sidelines
  • In This Story: Lightning

    Lightning is a giant spark of electricity in the atmosphere between clouds, the air, or the ground. Lightning can occur between opposite charges within the thunderstorm cloud (intra-cloud lightning) or between opposite charges in the cloud and on the ground (cloud-to-ground lightning). (Source: NSSL)

    2 Recent Items: Lightning

  • Cramer’s lightning round: Doximity is a winner
  • Cramer’s lightning round: You can buy more Ulta Beauty
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Final Trades: Moderna, Palo Alto Networks, Umpqua Holdings & more
  • Melbourne construction worker’s desperate message after COVID mistake | 7NEWS
  • Young Canberrans lining up for their first Moderna vaccine, open for 12 to 59-year-olds | ABC News
  • What’s fueling the world’s Covid-19 vaccination disparity? | Inside Story
  • Queensland pharmacies begin Moderna rollout | Coronavirus | 9 News Australia
  • In This Story: Novavax

    Novavax, Inc. (NASDAQ: NVAX) is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden.

    2 Recent Items: Novavax

  • What’s fueling the world’s Covid-19 vaccination disparity? | Inside Story
  • Novavax Sending 200 Million Vaccines to EU
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.